Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor—A Report of 3 Cases

Postow, 2018, Immune-related adverse events associated with immune checkpoint blockade, N Engl J Med, 378, 158, 10.1056/NEJMra1703481 Herrmann, 2020, Immune checkpoint inhibitors and immune-related adverse renal events, Kidney Int Rep, 5, 1139, 10.1016/j.ekir.2020.04.018 Cortazar, 2020, Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study, J Am Soc Nephrol, 31, 435, 10.1681/ASN.2019070676 Devuyst, 2009, Autoantibodies against intercalated cells in Sjogren’s syndrome, Kidney Int, 76, 229, 10.1038/ki.2009.112 Landry, 2019, Cloning, function, and localization of human, canine, and Drosophila ZIP10 (SLC39A10), a Zn(2+) transporter, Am J Physiol Renal Physiol, 316, F263, 10.1152/ajprenal.00573.2017 El Bitar, 2018, Renal tubular acidosis an adverse effect of PD-1 inhibitor immunotherapy, Case Rep Oncol Med, 2018, 8408015 Charmetant, 2020, A new expression of immune checkpoint inhibitors’ renal toxicity: when distal tubular acidosis precedes creatinine elevation, Clin Kidney J, 31, 435 Seethapathy, 2019, The incidence, causes, and risk factors of acute kidney injury in patients receiving immune checkpoint inhibitors, Clin J Am Soc Nephrol, 14, 1692, 10.2215/CJN.00990119 Rodriguez Soriano, 2002, Renal tubular acidosis: the clinical entity, J Am Soc Nephrol, 13, 2160, 10.1097/01.ASN.0000023430.92674.E5 DeFranco, 1995, Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjogren’s syndrome, J Am Soc Nephrol, 6, 295, 10.1681/ASN.V62295 Pereira, 2009, Molecular pathophysiology of renal tubular acidosis, Curr Genom, 10, 51, 10.2174/138920209787581262 van den Wildenberg, 2015, Distal renal tubular acidosis with multiorgan autoimmunity: a case report, Am J Kidney Dis, 65, 607, 10.1053/j.ajkd.2014.09.026 Caruana, 1988, The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases, Medicine (Baltimore), 67, 84, 10.1097/00005792-198803000-00002 Burki, 2015, Impaired expression of key molecules of ammoniagenesis underlies renal acidosis in a rat model of chronic kidney disease, Nephrol Dial Transplant, 30, 770, 10.1093/ndt/gfu384 Battistone, 2018, Extracellular adenosine stimulates vacuolar ATPase-dependent proton secretion in medullary intercalated cells, J Am Soc Nephrol, 29, 545, 10.1681/ASN.2017060643 Menzies, 2017, Purinergic signaling in kidney disease, Kidney Int, 91, 315, 10.1016/j.kint.2016.08.029 Khunger, 2017, Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials, Chest, 152, 271, 10.1016/j.chest.2017.04.177 Pillai, 2018, Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: a systematic analysis of the literature, Cancer, 124, 271, 10.1002/cncr.31043 De Sousa Linhares, 2019, Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling, Sci Rep, 9, 11472, 10.1038/s41598-019-47910-1 Dinour, 2004, A novel missense mutation in the sodium bicarbonate cotransporter (NBCe1/SLC4A4) causes proximal tubular acidosis and glaucoma through ion transport defects, J Biol Chem, 279, 52238, 10.1074/jbc.M406591200